PH4.F PATTIES FOODS

Healthcare Biotechnology Frankfurt Exchange
0.6054 EUR
Close of Nov 13, 2026
0.4471 1.12
Market cap
EUR 965M
P/E
-
P/B
5.59x
ROE
-70.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is PH4.F undervalued?

Graham number

The Graham number of PATTIES FOODS cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PATTIES FOODS fundamental analysis

No fundamental analysis for PATTIES FOODS yet.

PATTIES FOODS stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PATTIES FOODS

CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, and relapsed or refractory…

Full company profile